Technology
EnSilica to raise £0.3m through retail offer
EnSilica announced a retail offer through the Winterflood Retail Access Platform (WRAP) on Friday, to raise up to £0. 3m.
Recurring revenue, adjusted earnings rise for Pulsar Group
Audience intelligence software specialist Pulsar Group said in its final results on Friday that its annualised recurring revenue (ARR) increased £2. 7m, a significant improvement from the flat performance in the prior financial year.
Viavi offer for Spirent Communications officially lapses
Viavi Solutions confirmed on Friday that its proposed acquisition of Spirent Communications had lapsed.
Genedrive test ordered by five Manchester area hospitals
Point-of-care pharmacogenetic testing company Genedrive announced on Friday that it has received initial orders for its Genedrive MT-RNR1 products from five additional UK hospitals in the Greater Manchester area.
Avacta reports further progress in chemotherapy trial
Avacta Group announced the successful completion of the first cohort and the start of dosing for three patients in the second cohort of the second arm in its phase one trial of AVA6000, a peptide drug conjugate form of doxorubicin chemotherapy, on Thursday.
Cohort ends year slightly ahead of expectations
Technology company Cohort said in a trading update on Thursday that its full-year performance was slightly ahead of expectations, with growth in both revenue and profits year-on-year.
Public sector wins underpin growth for Bytes
Bytes Technology Group reported a strong set of preliminary results on Thursday, as gross invoiced income (GII) surged 26. 7% to £1. 82bn, driven by major contract wins in the public sector, notably with the NHS and HMRC, and sustained demand from corporate clients.
Niox trading in line with expectations
Asthma-focussed medical device company Niox said in an update on Wednesday that it continued to perform strongly in the year to date, meeting management expectations.
Idox flags solid first-half revenue growth
Information management software and geospatial data specialist Idox said in an update on Wednesday that it achieved revenue of around £43m in the first six months of the financial year, marking a year-on-year increase of over 20%.
Playtech confident despite recent betting challenges
Playtech reported a solid start to the year across its divisions in an update on Wednesday, despite some challenges around sports results.
IntegraFin reports record levels of funds under direction
Investment platform operator IntegraFin reported a strong financial and operational first half on Wednesday, with a record high level of funds under direction (FUD) on its Transact platform of £61bn on 31 March.
Cazoo reportedly lining up administrators
Cazoo, the online car retailer once valued at over £5bn, looked set to enter administration on Tuesday, according to Sky News.
Judges Scientific reports subdued start to year
Scientific instrument specialist Judges Scientific reported a subdued start to the year in an update on Tuesday, but said it was optimistic that it would still meet full-year consensus expectations.
Windward reports strong trading in year-to-date
Maritime artificial intelligence (AI) company Windward reported strong trading and strategic progress for the 2024 financial year in an update on Monday.
SDI Group set to end year in line with forecasts
Scientific digital imaging, sensing and control technology company SDI Group said in a trading update on Monday that, pending its final accounts and audit, it expected to report revenue of £65. 9m for the year, in line with current market expectations, but slightly down from £67. 6m in 2023.
Haydale Graphene lowers revenue expectations
Haydale Graphene lowered its forecast for full-year revenue to £4. 7m in a trading update on Monday, down from current market expectations of £5. 8m, but still an increase from the prior year's revenue of £4. 3m.
Nexxen reaffirms guidance after strong first quarter
Advertising technology company Nexxen International reported record programmatic revenue and significant growth in adjusted EBITDA in its first-quarter results on Monday.
PureTech Health launches $100m tender offer
Clinical-stage biotherapeutics company PureTech Health launched a proposed $100m tender offer on Monday, aiming to repurchase shares at a fixed price of 250p each, or £25. 00 per American depositary share (ADS).
AstraZeneca announces $1.5bn Singapore manufacturing facility
AstraZeneca announced plans to construct a $1. 5bn manufacturing facility in Singapore on Monday, dedicated to the production of antibody drug conjugates (ADCs).
Ethernity inks investment deal with New Tech Capital
Network processing semiconductor technology specialist Ethernity Networks announced a structured investment agreement with New Technology Capital Group (New Tech) on Friday.